Shelton Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-135,200
| Closed | -$1.2M | – | 738 |
|
|
2022
Q4 | $1.2M | Sell |
135,200
-10,200
| -7% | -$90.5K | 0.13% | 192 |
|
|
2022
Q3 | $1.78M | Sell |
145,400
-24,600
| -14% | -$301K | 0.08% | 206 |
|
|
2022
Q2 | $2.01M | Hold |
170,000
| – | – | 0.09% | 208 |
|
|
2022
Q1 | $3.23M | Sell |
170,000
-10,000
| -6% | -$190K | 0.12% | 176 |
|
|
2021
Q4 | $4.78M | Hold |
180,000
| – | – | 0.17% | 134 |
|
|
2021
Q3 | $7.39M | Buy |
180,000
+10,000
| +6% | +$411K | 0.29% | 80 |
|
|
2021
Q2 | $9.63M | Buy |
170,000
+38,000
| +29% | +$2.15M | 0.36% | 60 |
|
|
2021
Q1 | $5.54M | Buy |
132,000
+78,000
| +144% | +$3.28M | 0.19% | 114 |
|
|
2020
Q4 | $3.79M | Buy |
54,000
+19,000
| +54% | +$1.33M | 0.17% | 122 |
|
|
2020
Q3 | $982K | Hold |
35,000
| – | – | 0.04% | 343 |
|
|
2020
Q2 | $1.04M | Hold |
35,000
| – | – | 0.06% | 237 |
|
|
2020
Q1 | $694K | Buy |
35,000
+9,500
| +37% | +$188K | 0.05% | 241 |
|
|
2019
Q4 | $755K | Hold |
25,500
| – | – | 0.04% | 263 |
|
|
2019
Q3 | $580K | Buy |
25,500
+15,000
| +143% | +$341K | 0.03% | 307 |
|
|
2019
Q2 | $260K | Buy |
+10,500
| New | +$260K | 0.02% | 617 |
|